Site Management/Investigator Payments Featured Articles

  1. Site Staffing On The Upswing, But Still A Challenge 3/26/2026

    In this final article of the series, Jimmy Bechtel and Ken Getz discuss how workforce pressures have shaped site performance and what’s being done to strengthen site staff retention and career growth.

  2. Old Habits, Communication Issues Still Stalling Site Budget Negotiations 3/19/2026

    Drawing from the 2025 SCRS Landscape Survey Report, Jimmy Bechtel and Ken Getz unpack how growing trial complexity, inconsistent fair market value benchmarks, and structural disconnects are reshaping site-sponsor relationships.

  3. The Art Of Finding And Keeping The Right KOL 3/18/2026

    Learn from Incyclix CEO Patrick Roberts how the company identifies its KOLs, tailors engagement to their expertise, measures collaboration success, and sustains successful long-term partnerships.

  4. Do We Still Need To "Save" Our Sites? 3/11/2026

    Budget negotiations, sponsor expectations, operational pressures, and burnout all remained front-and-center concerns at this year's Save Our Sites (SOS) conference. In this recap, I share key takeaways from the sessions I attended — including practical budgeting advice, sponsor “turn-offs,” and a few unbelievable (but true) sponsor horror stories — along with why gatherings like SOS still matter for the site community.

  5. Avoid Clinical Alignment Breakdowns With "Lateral Agility" 3/6/2026

    Internal misalignment can stall the clinical timeline, erode the window of patent protection, and jeopardize funding. Learn why leadership can no longer be and instead must exhibit "lateral agility" across the enterprise.

  6. Why Africa Could Be The Next Frontier For Clinical Trials 3/6/2026

    Africa hosts only about 3% of global clinical trials despite representing roughly 20% of the world’s population. Tariro Makadzange, founder and CEO of the Africa Clinical Research Network (ACRN), explains how the organization aims to build a continent-wide clinical trial platform and increase that share to 15% over the next decade.

  7. How Keenova Reignited A Stalled Trial 3/3/2026

    When a difficult-to-enroll Phase 3 study stalled, Keenova found momentum not through new technology but through relationships, collaboration, and fair site support. By listening to site feedback, rethinking communication, empowering peer learning, and revisiting compensation, the team transformed engagement and enrollment. 

  8. The Uncomfortable Conversation: AI And Data Use In Clinical Trials 3/2/2026

    AI is quietly transforming clinical trials at the site level, boosting efficiency while creating hidden risks for patient data, protocols, and sponsor intellectual property.

  9. Tekton's CEO On The Growing Power Of Site Networks 2/27/2026

    Site networks continue to gain momentum as organizations emphasize operational consistency, shared infrastructure, and scale. Tekton Research CEO Corey Collins discusses how collaboration, sponsor dialogue, and real-world pressures like recruitment challenges and study delays are shaping the model — while it remains too early to know whether network-scale approaches will deliver meaningful efficiencies for sponsors.

  10. The Cost Of Transactional Thinking In Clinical Research 2/26/2026

    Denise N. Bronner of Empactful Ventures explores the power dynamics at play in clinical research, picking apart the roles of sponsors, vendors, and sites and advocating for a better way to do business among them.